Outsee has been selected for a Discovery Award from the Longitude Prize on ALS to support the use of the company’s artificial intelligence (AI)-based platform and large-scale patient genomic data to identify new therapeutic targets for amyotrophic lateral sclerosis (ALS). The Longitude Prize on ALS is a £7.5…
Outsee wins award to support AI search for ALS treatments
Statins, medications designed to lower cholesterol, do not meaningfully alter the risk of death or disease progression in people with amyotrophic lateral sclerosis (ALS), according to a study. The researchers said the findings show that ALS itself should not influence doctors’ decisions about prescribing statins. Instead, statins should be…
Differences in the inflammatory activity of certain immune cells may explain why amyotrophic lateral sclerosis (ALS) progresses faster in some people than others, according to a study. The findings suggest that it may be possible to slow ALS progression by targeting specific inflammatory disease markers. “The intensity of spinal…
Neurizon Therapeutics has received ethics approval for an Australia-based Phase 1 clinical trial that will test an oral liquid formulation of NUZ-001, which the company is developing for amyotrophic lateral sclerosis (ALS), in healthy volunteers. A tablet version of NUZ-001 is being tested in a Phase 2/3 clinical…
Today is my late husband’s 66th birthday. ALS took Jeff from our family just five days after he turned 60, and only 19 months after his diagnosis. Hearing the words, “This is ALS,” in the fall of 2018 was shocking and unbelievable. The early weeks and months after his…
An international team of scientists has developed an RNA-based experimental medicine that has the potential to reduce clumping of the TDP-43 protein, a key molecular feature of amyotrophic lateral sclerosis (ALS). The researchers determined, in precise molecular detail, how the RNA-based therapy interacts with the TDP-43 protein and showed…
In a recent episode of the “Hidden Brain” podcast, behavioral scientist Dave Evans discussed radical acceptance. He described his 69-year-old wife, Claudia, receiving a terminal cancer diagnosis and how they chose to skip the denial, anger, and depression that often come with grief. They moved straight to acceptance, allowing…
by Lindsey Beard
Families Are Waiting. I Know Because Mine Did.
When my father, Mickey, was diagnosed with amyotrophic lateral sclerosis (ALS), I was a sophomore in high school. Our world changed overnight. Like so many families, we were suddenly navigating a disease we barely understood — one that moves quickly and gives you very little time to adjust. We…
Dutch Bros is holding its annual Drink One for Dane Day of Giving fundraiser this Friday, May 15, with the Dutch Bros Foundation and franchisees donating $1 from every drink sold to support the fight against amyotrophic lateral sclerosis (ALS). The event raises funds and awareness of…
I spent five days last week corresponding with a fellow ALS patient in the U.K. We met during a unique online event that reminded me that, while this disease can feel isolating, the ALS community wraps all the way around the globe. Beyond the connection, I walked away with…
Recent Posts
- ‘Emily in Paris’ actor Pierre Deny dies following severe case of ALS
- Why I continue to volunteer and stay involved in ALS causes
- We replace an old feeding tube part with a ‘lifetime supply’ of new parts
- Living near green space may reduce risk of developing ALS
- Traumatic head injury and ALS linked, but relationship still unclear: Review